Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.03%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 33.50
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Byotrol, sareum, KDD ...

Thu, 19th Jul 2012 12:07

Byotrol, an anti-microbial hygiene company, has continued to make progress and has maintained the momentum seen in the second half of last year into the current financial year. The balance sheet continues to remain strong and is well positioned to its objective of positive cash generation at the earliest opportunity. The negotiations with its Fortune 150 customer are on track to deliver a full commercial agreement on time, while the product launches in conjunction with Rentokil Initial have been successful and the resulting order flow 'encouraging'.sareum, a specialist cancer drug discovery business, has said its financial results for the year ended June 30th will be broadly in line with market expectations, with the loss after tax for the year set to be around £0.64m. The firm said it and its collaborators continue to progress several commercial opportunities with its research programmes, with at least one of these deals will be concluded before the calendar year-end.Real estate investment group KDD has said it expects to received AMC approval - the only outstanding condition - by August 2nd for the sale of Sky Towers to Cimbrorum.Probability, a mobile gambling specialist, has agreed to acquire the entire issued share capital of Playyoo, a private company in Lugano, Switzerland, for an initial consideration of around £1.8m, satisfied by 2.4m shares in the company and a further 1.7m shares depending on the performance of Playyoo in 2013. The firm reported a loss before interest, tax, depreciation and amortisation of £0.127m in the year ended December 31st. It will be acquired free of debt. blinkx has promoted Chief Operating Officer Subhransu Mukherjee to the role Chief Executive Officer with immediate effect, and the now former CEO, Suranga Chandratillake, has put himself in the role of President and Chief Strategy Officer. The changes were Chandratillake's idea. Chandratillake, who is also a founder of the company, will be responsible for advancing the company's technology and product vision, and exploring new opportunities for growth. zamano, a mobile telecommunications company, has reported a solid performance in the first half of 2012 as it continues to benefit from the launch of a web and mobile service in the UK during the final quarter of 2011. The improved performance is expected to generate positive levels of operating cash to year end. Overall, the group is performing in line with expectations and is delivering on its objective to capitalise on its core technology and operational competencies. However, the firm warned that the outcome of the Comreg case and the current judicial review will determine the future of its SMS business in Ireland. Recruitment company Networkers International said it performed "very well" in the first half of 2012, with the gross margin for the six months set to increase around 17% year-on-year. Cash generation during the six-month period has also been strong with net debt expected to reduce by £2.8m to around £6.2m at the half year point. Serviced Office Group, a provider of office space and IT solutions, has been awarded a significant contract by Costain to cover its IT infrastructure requirements in connection with its work at London Bridge Station as part of the Thameslink upgrade programme. A key feature of the contract will be its focus on identifying environmentally-friendly solutions to Costain's IT requirements. Redhall Group, a specialist engineering support services group, has been awarded term contracts for Redhall Engineering and Redhall Nuclear. The first is to provide integrated multi-discipline engineering services to Polimeri Europa UK, estimated to have a value of £8.0m over a three year period. The second is for a three year multi-discipline framework agreement to provide support services across National Nuclear Laboratory nationally. A subsidiary of Rugby Estates has accepted an offer of 7p per share for its holding on 7.9m shares in O Twelve Estates. Under a separate agreement, either party can terminate the agreement on at least six months' written notice at any time. Seeing Machines, the maker of equipment that tracks the facial movements of drivers to make sure they are awake, has revealed that a South African distributor, Booyco Electronics has ordered a further 50 DSS units to enable it to quickly fulfil anticipated customer orders. Booyco has in the last six weeks delivered the two largest orders from Seeing Machine's distributors to date. These units will re-sell for a total of more than $0.5m, with Seeing Machines receiving the bulk of this upfront.Hardide, which provides metal surface engineering technology, has appointed Philip Kirkham as its new Chief Executive Officer with effect from September 1st 2012. He is a seasoned CEO with substantial international experience and a strong background in marketing, sales and production in the metal processing sector, the firm said. Between 2008 and 2009, he was CEO of private equity backed Material Advantage Group and since then he has been the CEO of a company operating in the industrial lighting industry. Walker Greenbank, a luxury interior furnishings group, has reported that its US business has won a $0.156m order to supply a substantial quantity of fabric to the Moody Gardens Hotel in Galveston, Texas. The order amounts to about 7.8km of a Sanderson-designed fabric in colourways developed specifically for the Moody Gardens Hotel's bedrooms and bathrooms. Hightex, a leading systems engineering company, has announced its wholly owned subsidiary, SolarNext, has won a significant contract to supply and install a thermal cooling system in an industrial production unit for a company based in Thuringia, Germany. The cooling system is the largest unit to be supplied by SolarNext to date. Its contract value is in excess of 0.25m euro, with all revenues expected to be received in the second half of 2012. The value of this one contract is close to the aggregate value of sales within Solarnext achieved in the whole of 2011.BrainJuicer, an international online market research agency, has delivered continued sales growth during the first half, with overall revenue some 13% ahead of the comparable 2011 period. Growth was seen in the US, Switzerland, China and Brazil, while revenues declined in Germany and the Netherlands and was broadly flat in the UK. "Overall, our percentage of revenue from our more innovative 'Juicy' products increased from 53% in H1 2011 to 66% in H1 2012," the firm said, adding that it believes it is on track to meet market profit expectations for 2012 as a whole.Advanced cleantech materials company Ilika posted a 30% rise in revenues to £2.01m (2011: £1.54m), gross profit of £0.82m, up 35% from £0.61m, loss before tax of £2.84m (2011: £3.15m) and loss per share of 0.07p (2011: 0.08p), for the year ended April 30th. "As we move into the new financial year we are confident that we've firmly established a strong base to continue to grow the business. We have a strong IP portfolio and a number of joint development agreements with major partners that continue to make good progress," the firm said. At the period end the group's cash position was £5.3m (2011: £2.8m). Petards, an AIM quoted developer of advanced security and surveillance systems, has secured a multi-million pound contract to supply Petards eyeTrain on-board digital CCTV systems. The order, worth in the region of £8.0m. Initial equipment deliveries are expected to commence later this year and to be completed by 2017. The highest proportion of equipment deliveries are scheduled to take place from 2014 onwards. Biome Technologies, a bioplastics business, said total revenue in the first half of 2012 was down £7.5m, 28% lower than the same period the previous year, pushed into decline by a downturn in sales within the Bioplastics Division following legislative changes in Italy and wider disruption to the supply and demand balance in Europe. In the second quarter group revenues were £2.9m, 38% below the revenues of £4.6m achieved in the first quarter. The Stanelco RF Technologies Division continues to perform as expected with revenues of £0.7m in the second quarter, up 95% compared to the first quarter (Q2 2011: £0.9m). The Bioplastics Division saw revenues drop from £4.3m in the first quarter to £2.2m in the second quarter (Q2 2011: £3.9m). The group's cash position at June 30th was £1.1m (April 30th: £1.5m).NR
More News
5 May 2023 15:53

Sareum gets approval for phase one psoriasis studies in Australia

(Sharecast News) - Biotechnology developer Sareum Holdings announced on Friday that it has been granted approval by Australia's Therapeutic Goods Administration (TGA) to conduct phase one clinical studies on SDC-1801.

Read more
5 May 2023 11:26

Sareum receives Australian approval for psoriasis drug clinical trial

Alliance News) - Sareum Holdings PLC on Friday said its application to start a phase 1 clinical trial in Australia of its lead product, psoriasis drug SDC-1801, has been approved.

Read more
5 May 2023 11:11

AIM WINNERS & LOSERS: Aptamer says struggling to convert pipeline

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
22 Mar 2023 11:47

Sareum Holdings interim loss widens as touts psoriasis candidate drug

(Alliance News) - Sareum Holdings PLC on Wednesday reported an increased half-year loss for the six months to December 31, as it continued to work on its psorasis candidate drug SDC-1801.

Read more
17 Mar 2023 18:06

IN BRIEF: Sareum makes trial application for SDC-1801 in Australia

Sareum Holdings PLC - Cambridge-based biotechnology company developing kinase inhibitors for autoimmune disease and cancer - On Wednesday, says it has begun an application to perform phase one clinical studies on SDC-1801 in Australia under the clinical trial notification scheme.

Read more
15 Mar 2023 15:43

UK earnings, trading statements calendar - next 7 days

Thursday 16 March 
Capital LtdFull Year Results
Centamin PLCFull Year Results
Deliveroo PLCFull Year Results
DFS Furniture PLCHalf Year Results
Empiric Student Property PLCFull Year Results
Eurocell PLCFull Year Results
FW ThorpeHalf Year Results (TBC)
Gelion PLCHalf Year Results
Gem Diamonds LtdFull Year Results
Gym Group PLCFull Year Results
Halma PLCTrading Statement
Helios Towers PLCFull Year Results
Hostmore PLCFull Year Results
Investec PLC and LtdTrading Statement
National World PLCFull Year Results
OSB Group PLCFull Year Results
PensionBee Group PLCFull Year Results
Polymetal International PLCfull Year Results
PYX Resources LtdFull Year Results
Rentokil Initial PLCFull Year Results
Restore PLCFull Year Results
Savills PLCFull Year Results
TI Fluid Systems PLCFull Year Results
WAG Payment Solutions PLCFull Year Results
Friday 17 March 
no events scheduled 
Monday 20 March 
Jubilee Metals Group PLCHalf Year Results
Tuesday 21 March 
Alliance Pharma PLCFull Year Results
Aptitude Software Group PLCFull Year Results
Boku IncFull Year Results
Diversified Energy Co PLCFull Year Results
Ergomed PLCFull Year Results
Fintel PLCFull Year Results
Gamma Communications PLCFull Year Results
Henry Boot PLCFull Year Results
Kape Technologies PLCFull Year Results
Kingfisher PLCFull Year Results
Luceco PLCFull Year Results
MP Evans Group PLCFull Year Results
Ocado Group PLCTrading Statement
Oxford Nanopore Technologies PLCFull Year Results
Pebble Group PLCFull Year Results
Quixant PLCFull Year Results
ScS Group PLCHalf Year Results
SThree PLCTrading Statement
Staffline Group PLCFull Year Results
Tissue Regenix Group PLCFull Year Results
Trustpilot Group PLCFull Year Results
YouGov PLCHalf Year Results
Zotefoams PLCFull Year Results
Wednesday 22 March 
Anpario PLCFull Year Results
Atalaya Mining PLCFull Year Results
BioPharma Credit PLCFull Year Results
Blackbird PLCFull Year Results
Bloomsbury Publishing PLCTrading Statement
Essentra PLCFull Year Results
Fevertree Drinks PLCFull Year Results
Genel Energy PLCFull Year Results
Gresham House PLCFull Year Results
Hostelworld Group PLCFull Year Results
Judges Scientific PLCFull Year Results
Kenmare Resources PLCFull Year Results
LSL Property Services PLCFull Year Results
Mpac Group PLCFull Year Results
NAHL Group PLCFull Year Results
Pendragon PLCFull Year Results
Pharos Energy PLCFull Year Results
Sareum Holdings PLCHalf Year Results
Ten Entertainment Group PLCFull Year Results
Tribal Group PLCFull Year Results
Vistry Group PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
6 Mar 2023 16:16

Sareum looks at options as GSK division returns cancer drug candidate

(Sharecast News) - Biotechnology developer Sareum announced on Monday that GSK subsidiary Sierra Oncology has returned clinical study reports and associated documents related to 'SRA737' to Sareum's co-development partner, the CRT Pioneer Fund.

Read more
6 Mar 2023 11:19

Sareum says GSK's Sierra returns clinical study reports to CRT Pioneer

(Alliance News) - Sareum Holdings PLC on Monday said that GSK PLC subsidiary Sierra Oncology Inc has completed the return of the clinical study reports relating to SRA737 to Sarerum's co-development partner CRT Pioneer Fund LP.

Read more
16 Dec 2022 21:53

TRADING UPDATES: Dev Clever to cancel shares; Tintra raises funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
16 Dec 2022 16:55

Sareum confident despite recent setbacks

(Sharecast News) - Autoimmune and cancer-focussed biotechnology company Sareum said in an update on Friday that it remained "confident" despite some recent setbacks.

Read more
16 Dec 2022 10:44

AIM WINNERS & LOSERS: Time Finance jumps on strong first-half results

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
9 Dec 2022 15:43

UK shareholder meetings calendar - next 7 days

Monday 12 December 
Devolver Digital IncSGM re 2022 Long-Term Incentive Plan approval
Marwyn Value Investors LtdAGM
Osirium Technologies PLCGM re placing agreement with Allenby Capital
PCF Group PLCGM re proposed cancellation of trading on AIM
Tuesday 13 December 
Amedeo Air Four Plus LtdAGM
Avation PLCAGM
Blancco Technology Group PLCAGM
JD Sports Fashion PLCGM re remuneration policy
Macau Property Opportunities Fund LtdAGM
Softcat PLCAGM
Spectris PLCGM re remuneration policy
Wednesday 14 December 
Fidelity Special Values PLCAGM
Kistos PLCGM re new non-operational entity
Parsley Box Group PLCGM re proposal to become a private limited company
TP Group PLCGM re cash acquisition
Volution Group PLCAGM
Westpac Banking CorpAGM
Thursday 15 December 
Aeorema Communications PLCAGM
Argos Resources LtdAGM
Baillie Gifford Japan Trust PLCAGM
Capricorn Energy PLCGM re proposed share premium account cancellation
Chelverton Growth Trust PLCAGM
CQS Natural Resources Growth & Income PLCAGM
DX Group PLCAGM
DXS International PLCAGM
Glenveagh Properties PLCEGM
Secured Income Fund PLCGM re proposed reduction of capital
Schroder Income Growth Fund PLCAGM
Friday 16 December 
Bellway PLCAGM
Inchcape PLCGM re Derco acquisition
JPMorgan Global Growth & Income PLCGM re proposed combination with JPMorgan Elect PLC
National Australia Bank LtdAGM
Sareum Holdings PLCAGM
Thor Explorations LtdAGM
UP Global Sourcing Holdings PLCAGM
  
Copyright 2022 Alliance News Ltd. All Rights Reserved.

Read more
21 Nov 2022 12:44

IN BRIEF: Sareum salutes publication of SRA737 combination trial data

Sareum Holdings PLC - Cambridge, England-based biotechnology company focused on developing kinase inhibitors for autoimmune disease & cancer - Says it is pleased by the publication of data from the Phase 1/2 trial of SRA737 as a combination treatment for advanced cancers in the medical journal, Clinical Cancer Research.

Read more
24 Oct 2022 10:28

IN BRIEF: Sareum widens annual loss; considers future of SRA737

Sareum Holdings PLC - Cambridge, England-based drug developer for cancer and autoimmune diseases - In the year ended June 30, pretax loss widens to GBP2.6 million from GBP1.7 million a year before. No revenue is recorded in either year, but in the previous year it brought in GBP171,000 in other operating income, with none recorded for financial 2022. Says it will discuss the future of SRA737 with partner Cancer Research Technology Pioneer Fund. Earlier this month, GSK PLC subsidiary Sierra Oncology Inc said it intends to return the rights for the SRA737 cancer treatment to CPF.

Read more
12 Oct 2022 10:47

Sareum plunges as GSK subsidiary Sierra returns rights for SRA737

(Alliance News) - Sareum Holdings PLC on Wednesday after Sierra Oncology Inc, a subsidiary of GSK PLC, said it intends to return the rights for SRA737 to the CRT Pioneer Fund LP.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.